Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

796 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Validity of the COmprehensive Score for financial Toxicity (COST) in patients with gynecologic cancer.
Kajimoto Y, Shibutani T, Nagao S, Yamaguchi S, Suzuki S, Mori M, Tsubouchi H, Nakao K, Azuma A, Koyanagi T, Kohara I, Tamaki S, Yabuki M, Teng L, Honda K, Igarashi A. Kajimoto Y, et al. Among authors: koyanagi t. Int J Gynecol Cancer. 2022 Apr 20:ijgc-2022-003410. doi: 10.1136/ijgc-2022-003410. Online ahead of print. Int J Gynecol Cancer. 2022. PMID: 35444012
Human papillomavirus vaccine impact on invasive cervical cancer in Japan: Preliminary results from cancer statistics and the MINT study.
Onuki M, Takahashi F, Iwata T, Nakazawa H, Yahata H, Kanao H, Horie K, Konnai K, Nio A, Takehara K, Kamiura S, Tsuda N, Takei Y, Shigeta S, Matsumura N, Yoshida H, Motohara T, Yamazaki H, Nakamura K, Hamanishi J, Tasaka N, Ishikawa M, Hirashima Y, Kudaka W, Mori-Uchino M, Kukimoto I, Fujii T, Watanabe Y, Noda K, Yoshikawa H, Yaegashi N, Matsumoto K; MINT Study Group. Onuki M, et al. Cancer Sci. 2023 Nov;114(11):4426-4432. doi: 10.1111/cas.15943. Epub 2023 Sep 8. Cancer Sci. 2023. PMID: 37688310 Free PMC article.
New criteria for the omission of lymphadenectomy in endometrioid carcinoma.
Matsushita C, Fujiwara H, Takei Y, Saga Y, Machida S, Taneichi A, Takahashi S, Yoshiba T, Koyanagi T, Takahashi Y, Morisawa H, Suzuki M. Matsushita C, et al. Among authors: koyanagi t. Int J Gynecol Cancer. 2019 Mar;29(3):541-546. doi: 10.1136/ijgc-2018-000044. Epub 2019 Jan 10. Int J Gynecol Cancer. 2019. PMID: 30630888
Efficacy and toxicity of pegylated liposomal doxorubicin as therapy for recurrent ovarian cancer in relation to the number of previous chemotherapy regimens: Comparison with gemcitabine.
Takahashi Y, Takei Y, Machida S, Taneichi A, Takahashi S, Yoshiba T, Koyanagi T, Tamura K, Saga Y, Fujiwara H. Takahashi Y, et al. Among authors: koyanagi t. J Obstet Gynaecol Res. 2021 Feb;47(2):551-559. doi: 10.1111/jog.14558. Epub 2020 Nov 4. J Obstet Gynaecol Res. 2021. PMID: 33145906
796 results